Senaste publikationer
-
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
Ingår i Frontiers in Pharmacology, 2023.
Artikel i tidskrift
DOI för Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development Ladda ner fulltext (pdf) av Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
-
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
Ingår i Frontiers in Pharmacology, 2023.
Artikel i tidskrift
DOI för Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development Ladda ner fulltext (pdf) av Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
-
Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP)
Ingår i BMJ Open, 2022.
Artikel i tidskrift
DOI för Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP) Ladda ner fulltext (pdf) av Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP)
-
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
Ingår i Pharmaceutics, 2022.
Artikel i tidskrift
DOI för Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis Ladda ner fulltext (pdf) av Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
-
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial
Ingår i American Journal of Respiratory and Critical Care Medicine, s. 1228-1235, 2022.
Artikel i tidskrift
-
Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial
Ingår i EClinicalMedicine, 2022.
Artikel i tidskrift
DOI för Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial Ladda ner fulltext (pdf) av Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial
-
Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics
Ingår i Clinical Microbiology and Infection, s. 448.e1-448.e7, 2022.
Artikel i tidskrift
DOI för Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics Ladda ner fulltext (pdf) av Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics
-
Finding the right hazard function for time-to-event modeling: A tutorial and Shiny application
Ingår i CPT, s. 991-1001, 2022.
Artikel i tidskrift
DOI för Finding the right hazard function for time-to-event modeling: A tutorial and Shiny application Ladda ner fulltext (pdf) av Finding the right hazard function for time-to-event modeling: A tutorial and Shiny application
-
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
Ingår i Pharmaceutics, 2022.
Artikel i tidskrift
DOI för Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin Ladda ner fulltext (pdf) av Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
-
A modeling-based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study
Ingår i CPT, s. 628-639, 2022.
Artikel i tidskrift
DOI för A modeling-based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study Ladda ner fulltext (pdf) av A modeling-based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study
-
Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical Data
Ingår i Journal of Infectious Diseases, s. 1876-1885, 2022.
Artikel i tidskrift
DOI för Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical Data Ladda ner fulltext (pdf) av Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical Data
-
Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
Ingår i BMJ Open, 2022.
Artikel i tidskrift
DOI för Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival Ladda ner fulltext (pdf) av Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
-
Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
Ingår i Frontiers in Pharmacology, 2022.
Artikel, forskningsöversikt
DOI för Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies Ladda ner fulltext (pdf) av Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
-
Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug
Ingår i CPT, s. 1628-1637, 2022.
Artikel i tidskrift
DOI för Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug Ladda ner fulltext (pdf) av Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug
-
Pharmacometrics in tuberculosis: progress and opportunities
Ingår i International Journal of Antimicrobial Agents, 2022.
Artikel i tidskrift
DOI för Pharmacometrics in tuberculosis: progress and opportunities Ladda ner fulltext (pdf) av Pharmacometrics in tuberculosis: progress and opportunities
-
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.
Ingår i European Respiratory Journal, 2021.
Artikel i tidskrift
-
Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model
Ingår i Journal of Infectious Diseases, s. 1039-1047, 2021.
Artikel i tidskrift
-
Mobile Health Apps for Improvement of Tuberculosis Treatment: Descriptive Review
Ingår i JMIR mhealth and uhealth, 2020.
Artikel, forskningsöversikt
DOI för Mobile Health Apps for Improvement of Tuberculosis Treatment: Descriptive Review
-
Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients
Ingår i Antimicrobial Agents and Chemotherapy, 2020.
Artikel i tidskrift
DOI för Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients Ladda ner fulltext (pdf) av Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients
-
Model-informed drug discovery and development strategy for the rapid development of anti-tuberculosis drug combinations
Ingår i Applied Sciences, 2020.
Artikel i tidskrift
DOI för Model-informed drug discovery and development strategy for the rapid development of anti-tuberculosis drug combinations Ladda ner fulltext (pdf) av Model-informed drug discovery and development strategy for the rapid development of anti-tuberculosis drug combinations
-
Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing: Using Rifampicin as an Example
Ingår i Frontiers in Pharmacology, 2020.
Artikel i tidskrift
DOI för Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing: Using Rifampicin as an Example Ladda ner fulltext (pdf) av Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing: Using Rifampicin as an Example
-
Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development
Ingår i Clinical Pharmacology and Therapeutics, s. 1285-1289, 2020.
Artikel i tidskrift
-
Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development.
Ingår i Clinical Pharmacology and Therapeutics, s. 274-286, 2020.
Artikel i tidskrift
DOI för Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development. Ladda ner fulltext (pdf) av Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development.
-
Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development
Ingår i Clinical and Translational Science, s. 1060-1064, 2020.
Artikel i tidskrift
DOI för Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development Ladda ner fulltext (pdf) av Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development
-
Anti‐tuberculosis effect of isoniazid scales accurately from zebrafish to humans
Ingår i British Journal of Pharmacology, s. 5518-5533, 2020.
Artikel i tidskrift
DOI för Anti‐tuberculosis effect of isoniazid scales accurately from zebrafish to humans Ladda ner fulltext (pdf) av Anti‐tuberculosis effect of isoniazid scales accurately from zebrafish to humans
-
Rifampicin can be given as flat-dosing instead of weight-band dosing
Ingår i Clinical Infectious Diseases, s. 3055-3060, 2020.
Artikel i tidskrift
DOI för Rifampicin can be given as flat-dosing instead of weight-band dosing Ladda ner fulltext (pdf) av Rifampicin can be given as flat-dosing instead of weight-band dosing
-
Rotational thromboelastometry can predict the probability of bleeding events in a translational rat model of haemophilia A following gene-based FVIIa prophylaxis
Ingår i Haemophilia, s. 164-172, 2020.
Artikel i tidskrift
-
A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis.
Ingår i Journal of Pharmacokinetics and Pharmacodynamics, s. 421-430, 2020.
Artikel i tidskrift
DOI för A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis. Ladda ner fulltext (pdf) av A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis.
-
Medical Device Apps: An Introduction to Regulatory Affairs for Developers
Ingår i JMIR mhealth and uhealth, 2020.
Artikel i tidskrift
DOI för Medical Device Apps: An Introduction to Regulatory Affairs for Developers Ladda ner fulltext (pdf) av Medical Device Apps: An Introduction to Regulatory Affairs for Developers
-
Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions
Ingår i Scientific Reports, 2020.
Artikel i tidskrift
DOI för Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions Ladda ner fulltext (pdf) av Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions
-
Individualised dosing algorithm and personalised treatment of high‐dose rifampicin for tuberculosis
Ingår i British Journal of Clinical Pharmacology, s. 2341-2350, 2019.
Artikel i tidskrift
-
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture
Ingår i Antimicrobial Agents and Chemotherapy, 2019.
Artikel i tidskrift
-
Consider ASCPT in Your End-of-Year Giving
Ingår i Clinical Pharmacology and Therapeutics, s. 17-21, 2019.
Artikel i tidskrift
-
Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia
Ingår i European Journal of Pharmaceutical Sciences, s. 196-203, 2018.
Artikel i tidskrift
-
Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors
Ingår i European Journal of Pharmaceutical Sciences, s. 531-538, 2018.
Artikel i tidskrift
-
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin
Ingår i Clinical Pharmacology and Therapeutics, s. 1208-1218, 2018.
Artikel i tidskrift
DOI för Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin Ladda ner fulltext (pdf) av Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin
-
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
Ingår i BMJ Open, 2018.
Artikel i tidskrift
DOI för Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study Ladda ner fulltext (pdf) av Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
-
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses
Ingår i Clinical Pharmacology and Therapeutics, s. 674-683, 2018.
Artikel i tidskrift
DOI för A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses Ladda ner fulltext (pdf) av A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses
-
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations
Ingår i Journal of Infectious Diseases, s. 991-999, 2018.
Artikel i tidskrift
-
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis
Ingår i Clinical Infectious Diseases, s. 34-41, 2018.
Artikel i tidskrift
DOI för The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis Ladda ner fulltext (pdf) av The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis
-
Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting
Ingår i Journal of Antimicrobial Chemotherapy, s. 2838-2845, 2018.
Artikel i tidskrift
-
A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations
Ingår i Journal of Antimicrobial Chemotherapy, s. 437-447, 2018.
Artikel i tidskrift
DOI för A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations Ladda ner fulltext (pdf) av A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations
-
Comparisons of analysis methods for assessment of pharmacodynamic interactions including design recommendations
Ingår i AAPS Journal, 2018.
Artikel i tidskrift
DOI för Comparisons of analysis methods for assessment of pharmacodynamic interactions including design recommendations Ladda ner fulltext (pdf) av Comparisons of analysis methods for assessment of pharmacodynamic interactions including design recommendations
-
The implications of model-informed drug discovery and development for tuberculosis
Ingår i Drug Discovery Today, s. 481-486, 2017.
Artikel, forskningsöversikt
DOI för The implications of model-informed drug discovery and development for tuberculosis
-
Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approaches
Ingår i Journal of Pharmacokinetics and Pharmacodynamics, s. 325-333, 2017.
Artikel i tidskrift
-
Assessing Pharmacodynamic Interactions in Mice using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models
Ingår i CPT, s. 787-797, 2017.
Artikel i tidskrift
DOI för Assessing Pharmacodynamic Interactions in Mice using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models Ladda ner fulltext (pdf) av Assessing Pharmacodynamic Interactions in Mice using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models
-
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods
Ingår i Journal of Antimicrobial Chemotherapy, s. 2311-2319, 2017.
Artikel i tidskrift
DOI för Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods Ladda ner fulltext (pdf) av Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods
-
Residual Spinal Cord Compression Following Hemilaminectomy and Mini-Hemilaminectomy in Dogs: A Prospective Randomized Study
Ingår i Frontiers in Veterinary Science, 2017.
Artikel i tidskrift
-
A Pharmacokinetic-Pharmacodynamic Model of Morphine Exposure and Subsequent Morphine Consumption in Postoperative Pain
Ingår i Pharmaceutical research, s. 1093-1103, 2016.
Artikel i tidskrift